Phio Pharmaceuticals Corp (PHIO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.07
• Market Cap: $15.79M
• EPS: $-2.09
• 52-Week High: $3.48
• 52-Week Low: $0.81

Market Sentiment

Phio Pharmaceuticals Corp currently has a Bullish sentiment score of 0.45.

About Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corp. is a biotechnology firm based in Marlborough, Massachusetts, focused on developing groundbreaking therapeutics that harness the power of the immune system to combat cancer. Utilizing its proprietary self-delivering RNA interference (RNAi) technology, the company aims to create transformative treatments that enhance efficacy while minimizing adverse effects. With a strong pipeline of innovative product candidates, Phio is well-positioned to play a significant role in...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Phio Pharmaceuticals Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PHIO pay dividends?

Phio Pharmaceuticals Corp (PHIO) does not currently pay a regular dividend.

What is PHIO's market cap?

Phio Pharmaceuticals Corp (PHIO) has a market capitalization of $15.79M with a current stock price of $1.07.